Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | CRHBP | P24387 | 1/20 | 0.31 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.31 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.30 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21019993 | 0.90 | SIGMAR1 (0.33) | SIGMAR1CRHBPCRHR2KIF11GABRA1 | |
| SCHEMBL20172840 | 0.88 | P2RX7 (0.35) | SIGMAR1CRHBPCRHR2KIF11 | |
| SCHEMBL21019995 | 0.86 | SIGMAR1 (0.37) | SIGMAR1GABRA1GABRB2CYP3A4 | |
| SCHEMBL20172831 | 0.86 | KIF11 (0.35) | SIGMAR1KIF11ALDH1A1CYP2C19 | |
| SCHEMBL20650483 | 0.86 | SIGMAR1 (0.30) | SIGMAR1KIF11 | |
| SCHEMBL20067365 | 0.84 | — | — | |
| SCHEMBL20172795 | 0.82 | GPR55 (0.38) | SIGMAR1GABRA1GABRB2ALDH1A1CYP3A4 | |
| SCHEMBL20172830 | 0.82 | GABRA1 (0.37) | KIF11GABRA1GABRB2ALDH1A1CYP2C19 | |
| SCHEMBL24501820 | 0.81 | GABRA1 (0.35) | KIF11GABRA1GABRB2ALDH1A1CYP3A4 | |
| SCHEMBL20172826 | 0.81 | KIF11 (0.32) | KIF11CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10651411-B2 | Compound and organic light emitting device containing same | LG CHEM, LTD. (KR) | 2020-05-12 | — | — | US | disclosed |
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | CRY1, CRY2, OR10J3 | SIGMAR1 1467/4885CRHBP 4544/4885CRHR2 4194/4885 |
| US-10651411-B2 | Compound and organic light emitting device containing same | CRY1, CRY2, OR10J3 | SIGMAR1 1467/4885CRHBP 4544/4885CRHR2 4194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.